(Total 7 high profile publication citations)

Svanberg, C., Prasad Mukku, R., Besler, S. O., Hopkins, F. R., Sjöwall, C., Nyström, S., ... & Larsson, M. (2026). HIV-1 derived oligonucleotides induce a type I IFN/STING dependent immune suppression reversible by targeting IFNARI. PLoS Pathogens, 22(1), e1013868.

 

Cuoco, C. A., Ren, W., Baron, K. R., Gologo, S., Perea, V., Mathur, P., ... & Kelly, J. W. (2025). Pharmacological targeting of RIG-I can selectively activate the integrated stress response. Science Advances, 11(44), eadt3014.

 

Svanberg, C., Mukku, R. P., Besler, Ö., Hopkins, F. R., Sjöwall, C., Nyström, S., ... & Larsson, M. (2025). HIV-1 derived replication intermediates/oligonucleotides induce a type I IFN-dependent immune suppression via STING activation that can be restored by targeting IFNARI. bioRxiv, 2025-02.

 

Alaimo, A., Genovesi, S., Annesi, N., De Felice, D., Subedi, S., Macchia, A., ... & Lunardi, A. (2024). Sterile inflammation via TRPM8 RNA-dependent TLR3–NF-κB/IRF3 activation promotes antitumor immunity in prostate cancer. The EMBO Journal, 43(5), 780–805.

 

Chen, J., Wang, Q., Zhong, B., Zheng, H., Wang, D., Huang, X., ... & Liu, T. (2024). Activation of the RIG-I/MAVS signaling pathway during human adenovirus type 3 infection impairs the pro-inflammatory response induced by secondary infection with Staphylococcus aureus. International Journal of Molecular Sciences, 25(8), 4178.

 

Fu, L., Gilham, D., Stotz, S. C., Sarsons, C. D., Rakai, B. D., Tsujikawa, L. M., ... & Kulikowski, E. (2023). Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA-induced inflammation. International Immunopharmacology, 117, 109929.

 

Nakai, K., Lin, H., Yamano, S., Tanaka, S., Kitamoto, S., Saitoh, H., ... & Kon, S. (2023). Wnt activation disturbs cell competition and causes diffuse invasion of transformed cells through NF-κB–MMP21 pathway. Nature Communications, 14(1), 7048.